Key facts
- This page summarizes Kenneth D. Eichenbaum's Form 3 filing for FEMASYS INC (FEMY).
- 0 reported transactions and 4 derivative rows are listed below.
- Accepted by SEC: 24 Mar 2026, 18:06.
Kenneth D. Eichenbaum - 18 Mar 2026 Form 3 Insider Report for FEMASYS INC (FEMY)
- Reporting relationship
- Director
- Issuer ticker
- FEMY
- Reported as of
- 18 Mar 2026
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 24 Mar 2026, 18:06:46 UTC
- Prior SEC filing
- 28 May 2025
- Next SEC filing
- 27 Mar 2026
- Source filing
- View source filing
- Reporting owner signature
- s/ Kathy Lee-Sepsick, Attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Kenneth D. Eichenbaum filed Form 3 for FEMASYS INC (FEMY) on 24 Mar 2026.
Change
- Previous filing in this sequence was filed on 28 May 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0002024404
Primary reporting owner
Eichenbaum Kenneth D.
- Relationship
- Director
- Address
- C/O FEMASYS INC., 3950 JOHNS CREEK COURT, SUITE 100, SUWANEE
- Signature
- s/ Kathy Lee-Sepsick, Attorney-in-fact
- Signature date
- 24 Mar 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
FEMY
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 25,010
- Date
- 18 Mar 2026
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
FEMY
holding
Derivative
Senior Secured Convertible Notes
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- Common stock, par value $0.001 per share
- Underlying amount
- 102,366
- Exercise price
- $0.7300
- Footnotes
- F1, F5, F7
FEMY
holding
Derivative
Series A-1 Warrants
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- Common stock, par value $0.001 per share
- Underlying amount
- 102,366
- Exercise price
- $0.8100
- Footnotes
- F2, F6, F7
FEMY
holding
Derivative
Series B-1 Warrants
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- Common stock, par value $0.001 per share
- Underlying amount
- 102,366
- Exercise price
- $0.9200
- Footnotes
- F3, F6, F7
FEMY
holding
Derivative
Series C-1 Warrants
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- Common stock, par value $0.001 per share
- Underlying amount
- 102,366
- Exercise price
- $1.10
- Footnotes
- F4, F6, F7
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 7 footnotes
Footnote F1
Holder may, at its option, prior to maturity, convert all or any portion of the outstanding amount of Senior Secured Convertible Notes due 2035 (the "Convertible Notes"), including accrued paid in-kind interest thereon, subject to certain limitations, into shares of Common Stock, at an initial conversion price of $0.73 per share of Common Stock. The conversion rate is subject to adjustment in accordance with the terms of the Convertible Notes and will be subject to standard adjustments in the event of any stock split, stock dividend, stock combination, recapitalization or other similar transactions.
Footnote F2
Holder may, at its option, exercise the Series A-1 Warrants, subject to the terms and conditions thereof, at an initial exercise price of $0.81 per share of Common Stock. The exercise price is subject to adjustment in accordance with the terms of the Series A-1 Warrants and will be subject to standard adjustments in the event of any stock split, stock dividend, stock combination, recapitalization or other similar transactions.
Footnote F3
Holder may, at its option, exercise the Series B-1 Warrants, subject to the terms and conditions thereof, at an initial exercise price of $0.92 per share of Common Stock. The exercise price is subject to adjustment in accordance with the terms of the Series B-1 Warrants and will be subject to standard adjustments in the event of any stock split, stock dividend, stock combination, recapitalization or other similar transactions.
Footnote F4
Holder may, at its option, exercise the Series C-1 Warrants, subject to the terms and conditions thereof, at an initial exercise price of $1.10 per share of Common Stock. The exercise price is subject to adjustment in accordance with the terms of the Series C-1 Warrants and will be subject to standard adjustments in the event of any stock split, stock dividend, stock combination, recapitalization or other similar transactions.
Footnote F5
Represents the maximum number of shares of Common Stock issuable upon the voluntary conversion of the original stated amount of the Convertible Notes. The number of shares issuable upon conversion of the Convertible Notes is subject to increase in connection with the accrual of interest, which is payable in kind. The Holder's ability to convert the Convertible Notes to shares of Common Stock is subject to certain limitations, in accordance with rules of the Nasdaq Capital Market.
Footnote F6
The Holder's ability to exercise the subject Warrant for shares of Common Stock is subject to certain limitations, in accordance with rules of the Nasdaq Capital Market.
Footnote F7
The reported securities were purchased by the reporting person for an aggregate amount of $75,000.